Diabetes Board decisions

The Board granted service connection for diabetes mellitus, type II, hypertension, and prostate cancer as due to exposure to herbicides. It also granted service connection for erectile dysfunction, nephropathy, bilateral lower extremity peripheral neuropathy, bilateral upper extremity peripheral neuropathy, and diabetic retinopathy as secondary to the already service-connected conditions of diabetes mellitus or prostate cancer.

The Veteran's claims for service connection for hypertension and diabetes mellitus, type II were dismissed due to a failure to follow the relevant claims processing rules.

The Veteran's service-connected disabilities have rendered him unable to secure or follow substantially gainful employment from August 11, 2023.

The Board denied the veteran's claims for increased ratings and service connection, finding no evidence to support higher ratings or a link between his claimed conditions and military service.

The Board denied service connection for heart problem, sleep apnea, diabetes, stroke, tinnitus, GERD, and hypertension as new and relevant evidence was not received to support the claims.

The Board remands the claim for service connection for type II diabetes mellitus, peripheral neuropathy, and vision problems to the AOJ for adjudication of the request to substitute for accrued benefits purposes.

The Board granted service connection for tinnitus and diabetes mellitus type II, but denied a compensable rating for bilateral hearing loss and erectile dysfunction prior to December 18, 2020. The Board also granted service connection for hypertension as aggravated beyond the natural progression of a pre-existing disorder.

The Board remands the claims for service connection for various conditions, including diabetes mellitus type I and rheumatoid arthritis of multiple joints, as well as Hashimoto's thyroiditis and diabetic retinopathy, due to inadequate medical opinions regarding their relationship to in-service toxic exposure.

The Board granted service connection for PTSD and erectile dysfunction, but denied service connection for headaches, left hand disability, left knee disability, left shoulder disability, right foot disability, right arm/shoulder disability, diabetes, and individual unemployability. The claim for service connection for a psychiatric disorder was granted.

The Board remands the claims for service connection for various conditions, including bilateral hearing loss, tinnitus, low back condition, COPD, brain condition, diabetes mellitus type II, GERD, heart condition, and hypertension, to obtain additional evidence.

The Board denied the Veteran's claims for increased ratings for obstructive sleep apnea, type II diabetes mellitus, atrial fibrillation with rapid ventricular rate, and hypertension. However, a 60 percent rating was granted for coronary artery disease effective May 24, 2023.

The Board granted an initial 100 percent rating for Parkinson's disease with major neurocognitive disorder and a 100 percent rating for loss of use of both feet and hands from June 7, 2021. The other claims were denied.

The Board denied increased ratings for PTSD, diabetes mellitus type II, left and right lower extremity peripheral neuropathy, and a TDIU.

The Board granted service connection for diabetes, hypertension, and erectile dysfunction as secondary to the Veteran's service-connected acquired psychiatric disorder. The claim for a compensable rating for bilateral hearing loss was denied.

The Board remands the claims for service connection for diabetes, high blood pressure, a skin rash, and neuropathy of both upper and lower extremities due to additional development needed to identify specific toxic exposures during the Veteran's service.

The Board denied increased ratings for peripheral neuropathy and remanded claims related to eye conditions and TDIU.

The Board granted service connection for diabetes mellitus type 2 and prostate cancer, finding a causal relationship between the Veteran's in-service exposure to defoliant agents and these conditions.

The Board remands the claims for service connection for diabetes mellitus type II, trigeminal neuralgia, and intraocular melanoma tumor of the right eye due to contaminated water exposure at Camp Lejeune for a new VA etiology opinion.

The Board denied the appeal, affirming the severance of service connection for various conditions due to clear and unmistakable errors in the prior decision.

The Board granted service connection for diabetes, ischemic heart disease, hypertension, and neuropathy of the right and left upper and lower extremities as secondary to diabetes due to herbicide exposure during the Veteran's service in Okinawa.